0001782226-20-000002.txt : 20201201 0001782226-20-000002.hdr.sgml : 20201201 20201201120603 ACCESSION NUMBER: 0001782226-20-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20201201 DATE AS OF CHANGE: 20201201 EFFECTIVENESS DATE: 20201201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: i2O Therapeutics, Inc. CENTRAL INDEX KEY: 0001782226 IRS NUMBER: 841743853 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-381826 FILM NUMBER: 201360295 BUSINESS ADDRESS: STREET 1: 13250 VIA ARRIBA DRIVE CITY: SARATOGA STATE: CA ZIP: 95070 BUSINESS PHONE: 408-476-1904 MAIL ADDRESS: STREET 1: 13250 VIA ARRIBA DRIVE CITY: SARATOGA STATE: CA ZIP: 95070 D 1 primary_doc.xml X0708 D LIVE 0001782226 i2O Therapeutics, Inc. 13250 VIA ARRIBA DRIVE SARATOGA CA CALIFORNIA 95070 408-476-1904 DELAWARE None None Corporation true 2019 Ravi Srinivasan c/o i2O Therapeutics, Inc. 13250 via Arriba Drive Saratoga CA CALIFORNIA 95070 Executive Officer Director Samir Mitragotri c/o i2O Therapeutics, Inc. 13250 via Arriba Drive Saratoga CA CALIFORNIA 95070 Executive Officer Director Katie Ellias c/o i2O Therapeutics, Inc. 13250 via Arriba Drive Saratoga CA CALIFORNIA 95070 Director Christopher Gagliardi c/o i2O Therapeutics, Inc. 13250 via Arriba Drive Saratoga CA CALIFORNIA 95070 Director Biotechnology Decline to Disclose 06b false 2020-11-16 false true false 0 600000 600000 0 false 2 0 0 0 false i2O Therapeutics, Inc. /s/ Ravi Srinivasan Ravi Srinivasan President 2020-12-01